Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 50 (5), 734-739
- https://doi.org/10.1016/s0190-9622(03)00792-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Tazarotene plus UVB phototherapy in the treatment of psoriasisJournal of the American Academy of Dermatology, 2000
- PUVA and cancer risk: the Swedish follow-up studyBritish Journal of Dermatology, 1999
- Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA‐bath versus PUVA‐cream therapyPhotodermatology, Photoimmunology & Photomedicine, 1999
- PUVA Inhibits DNA Replication, but not Gene Transcription at Nonlethal DosagesJournal of Investigative Dermatology, 1998
- Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).JCI Insight, 1998
- Malignant Melanoma in Patients Treated for Psoriasis with Methoxsalen (Psoralen) and Ultraviolet A Radiation (PUVA)New England Journal of Medicine, 1997
- Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells.The Journal of Experimental Medicine, 1995
- Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasisJournal of the American Academy of Dermatology, 1993
- 311 nm UVB phototherapy—an effective treatment for psoriasisBritish Journal of Dermatology, 1988
- PUVA therapy for psoriasis: Comparison of oral and bath-water delivery of 8-methoxypsoralenJournal of the American Academy of Dermatology, 1986